French watchdogs allow Cerba to buy biomed rival Bio 7
MLex Summary: The French competition authority has cleared the acquisition of the medical biology group Bio 7 group by its rival Cerba, finding that it is not likely to harm competition....To view the full article, register now.
Already a subscriber? Click here to view full article